Complement activation initiates a cascade reaction that generates bioactive components (C3b, C3a, C5a, and C5b-9) with proinflammatory, chemo-attractant, and cell-damaging functions.[5] A few observations suggested that activation of the complement system might be involved in the pathophysiology of SSc and SRC. The gene discussed is C3; the disease is systemic sclerosis.